Zomedica Corp. Quarterly Deferred Income Tax Expense (Benefit) in USD for Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Zomedica Corp. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate for Q1 2024.
- Zomedica Corp. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$184K.
- Zomedica Corp. annual Deferred Income Tax Expense (Benefit) for 2023 was -$1.49M, a 41.4% increase from 2022.
Deferred Income Tax Expense (Benefit), Quarterly (USD)